BIO-key International, Inc. (BKYI) Stock Score, Valuation & Financial Research

BIO-key International, Inc. is in the Technology sector and Information Technology Services industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 23/100.

Quick answer for BKYI

BIO-key International, Inc. currently has a Wall Street Score of 23/100. The stored market price is $2.62. Its financial score is 22/100. Its valuation score is 0/100. These figures are a research snapshot, not a buy or sell recommendation.

What BIO-key International, Inc. does

BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions in the United States and internationally. It offers BIO-key PortalGuard and PortalGuard IDaaS cloud-based identity platforms, which allows authentication through an IAM platform; and BIO-key VST and WEB-key; civil and large-scale ID infrastructure. The company also provides fingerprint readers for commercial companies under the SidePass, SideSwipe, and EcoID II brands; and identity and access management, user multi-factor authentication, single sign on, privilege entitlement, and access control. It serves commercial, government, and education customers. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 a

BKYI financial snapshot

Wall Street Score:
23/100
Current price:
$2.62
Market capitalization:
$2.8M
Revenue:
$6.9M
Net income:
$-3.4M
Free cash flow:
$-4.7M
Cash:
$1.4M
Total debt:
$150K
EPS:
-4.07
Financial score:
22/100
Valuation score:
0/100
Revenue score:
33/100

What stands out

  • Reported year-over-year revenue growth is +0.1%.
  • Free cash flow is $-4.7M, showing cash burn in the current stored period.
  • The balance sheet shows $1.4M of cash versus $150K of total debt, leaving more cash than debt.
  • The current research record carries a corporate distress warning, which should be reviewed alongside the score.

What the numbers mean

Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.

The financial score is 22/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.

A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.

Data freshness: Financial data last refreshed 2026-09-09.

How to research BKYI

Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.

Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks

Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.